Catheter‑Related Bloodstream Infection (CRBSI) – Evidence‑Based Diagnosis and Management

Diagnosis

Obtain two sets of blood cultures before antimicrobial therapy – one from a peripheral vein and one from the catheter, with bottles clearly labeled by collection site.  1
Paired peripheral‑catheter sampling is essential to differentiate true CRBSI from contaminant or non‑catheter‑related bacteremia. 2
Definitive CRBSI is confirmed when the same organism is isolated from (a) a catheter‑tip culture and a peripheral blood culture, or when paired catheter‑peripheral blood cultures meet quantitative or differential time‑to‑positivity (DTP) criteria. 1
Quantitative criterion: colony count from catheter‑drawn blood must be ≥ 3‑fold higher than that from peripheral blood. 1
DTP criterion: the catheter‑drawn culture becomes positive ≥ 2 hours earlier than the peripheral culture. [2][3]
DTP may be unreliable in patients already receiving antibiotics, because prior therapy can mask the time difference. 2

Empirical Antimicrobial Therapy

Gram‑positive coverage: use vancomycin in settings with high MRSA prevalence; switch to daptomycin when local MRSA isolates have a vancomycin MIC > 2 µg/mL. [2][3]
Avoid linezolid for empiric therapy before bloodstream infection is proven. [2][3]
Gram‑negative coverage: select a fourth‑generation cephalosporin, carbapenem, or β‑lactam/β‑lactamase inhibitor based on the institution’s antibiogram and the patient’s severity of illness. [2][3]
MDR organisms: provide dual gram‑negative agents for neutropenic, severely septic patients, or those colonized with Pseudomonas aeruginosa until susceptibilities permit de‑escalation. [2][3]
Femoral catheter CRBSI in critically ill patients: add gram‑negative and Candida coverage empirically. [2][3]
Empiric antifungal therapy (echinocandin preferred; fluconazole if no recent azole exposure and low risk of C. krusei/glabrata) is indicated for patients with risk factors such as total parenteral nutrition, prolonged broad‑spectrum antibiotics, hematologic malignancy, transplant, femoral catheter, or multi‑site Candida colonization. [2][3]

Pathogen‑Specific Management

Staphylococcus aureus: immediate catheter removal and 4–6 weeks of systemic therapy. [4][5]
Persistent bacteremia > 72 h after catheter removal and appropriate antibiotics mandates a minimum 4‑week treatment course. [4][5]
Coagulase‑negative Staphylococci (short‑term catheters): catheter removal plus 5–7 days of therapy when fever/bacteremia resolves within 72 h. [4][5]
Enterococcus spp.: catheter removal and 7–14 days of therapy. [4][5]
Gram‑negative bacilli: catheter removal and 7–14 days of therapy. [4][5]
Candida spp.: immediate catheter removal and 14 days of antifungal therapy after the first negative blood culture. [4][5]

Antibiotic Lock Therapy (ALT)

ALT is restricted to long‑term catheters when catheter salvage is desired and there is no exit‑site or tunnel infection. [6][7]
ALT must be combined with systemic antibiotics for a total of 10–14 days. [6][7]
Vancomycin lock concentration should be ≥ 1000 × MIC (≈ 5 mg/mL). [6][7]
Dwell time ≤ 48 h before catheter re‑use; for ambulatory patients with femoral catheters, a 24‑h dwell is preferred. [6][7]
In hemodialysis patients, the lock solution is renewed after each dialysis session. [6][7]
Contraindicated for S. aureus or Candida CRBSI – catheter removal is mandatory. [6][7]
Reported success rates: 87–100 % for gram‑negative organisms, 75–84 % for S. epidermidis, and 40–55 % for S. aureus. [6][7]

Hemodialysis Catheter‑Specific Management

For coagulase‑negative Staphylococci or non‑Pseudomonas gram‑negatives, start empirical IV antibiotics without immediate removal; if symptoms resolve within 2–3 days and no metastatic infection is evident, the catheter may be exchanged over a guidewire. 8
Persistent symptoms or evidence of metastatic infection requires immediate catheter removal. 8
Standard pathogen‑specific durations apply for uncomplicated infections. 5
Persistent bacteremia/fungemia > 72 h after removal: 4–6 weeks of therapy. 8
Endocarditis or suppurative thrombophlebitis: 4–6 weeks of therapy. 8
Osteomyelitis: 6–8 weeks of therapy. 8
Cefazolin dosing for MSSA in dialysis patients: 20 mg/kg (actual body weight) after each dialysis session. 8
Empiric regimen for dialysis catheters: vancomycin plus gram‑negative coverage (third‑generation cephalosporin, carbapenem, or β‑lactam/β‑lactamase inhibitor) guided by local antibiogram. 8
After catheter retention with treatment, obtain surveillance blood cultures 1 week after completing antibiotics. 8
If surveillance cultures are positive, remove the catheter and place a new long‑term catheter only after negative cultures are confirmed. 8
Guidewire exchange does not require a pre‑exchange negative culture when the patient remains asymptomatic. 8

Duration of Therapy (Key Timing)

Day 1 is defined as the first day that negative blood cultures are obtained. [2][3]
Persistent bacteremia/fungemia > 72 h despite appropriate therapy: minimum 4–6 weeks of treatment. [2][3]
Endocarditis or suppurative thrombophlebitis: 4–6 weeks of therapy. [2][3]
Osteomyelitis: 6–8 weeks of therapy. [2][3]

Critical Pitfalls to Avoid

Do NOT use linezolid empirically before bloodstream infection is confirmed. [2][3]
Do NOT employ ALT alone without concurrent systemic antibiotics. [6][7]
Do NOT attempt catheter salvage with ALT for S. aureus or Candida CRBSI; removal is mandatory. [6][7]

Catheter Removal vs. Retention

Mandatory removal for infections caused by S. aureus or Candida (any catheter type). [4][5]
Removal also required for persistent bacteremia/fungemia > 72 h despite appropriate therapy. [4][5]
Severe sepsis, suppurative thrombophlebitis, or endocarditis necessitate catheter removal. 3
Tunnel infection or port abscess and hemodynamic instability despite therapy also mandate removal. 9
Consider retention (long‑term catheters) for coagulase‑negative Staphylococci or non‑Pseudomonas gram‑negatives when there is no exit‑site/tunnel infection, using systemic antibiotics plus ALT. [6][7]
For hemodialysis catheters, retention is acceptable for the same organisms if symptoms resolve within 2–3 days and no metastatic infection is present; catheter may be exchanged over a guidewire. 8

Catheter‑Related Bloodstream Infection (CRBSI) Management Guidelines

Initial Management

Immediate removal of the catheter and initiation of systemic antimicrobial therapy directed at the identified pathogen is recommended; treatment duration is determined by the specific organism and clinical response. 10
For short‑term central venous or arterial catheters, routine removal is the standard approach for most CRBSI cases. 10
Catheters must be removed promptly when the causative organism is Staphylococcus aureus or Candida species. 10
In hemodialysis catheters, removal is mandatory for S. aureus, Pseudomonas species, or Candida species. 11
Consider catheter removal if bacteremia or fungemia persists > 72 hours despite appropriate antimicrobial therapy. 10
Obtain two sets of blood cultures—one from a peripheral site and one from the catheter (if still in place)—to confirm the diagnosis and guide management. 10

Pathogen‑Specific Management

Staphylococcus aureus

Remove the catheter immediately and administer 4–6 weeks of systemic antimicrobial therapy. 12
A shortened course (≥ 14 days) is acceptable only when all of the following are met: patient is not diabetic or immunosuppressed, catheter has been removed, no prosthetic intravascular devices are present, a transesophageal echocardiogram performed 5–7 days after onset shows no endocarditis, fever and bacteremia resolve within 72 hours of appropriate therapy, and there is no evidence of metastatic infection. 12
For methicillin‑susceptible S. aureus (MSSA) in patients without β‑lactam allergy, switch from vancomycin to cefazolin (or another β‑lactam) to improve outcomes. 10
In hemodialysis patients with MSSA, give cefazolin 20 mg/kg (actual body weight) after each dialysis session. 11

Coagulase‑Negative Staphylococci

When the catheter is removed and the infection is uncomplicated, treat for 5–7 days with systemic antibiotics. 13
If catheter retention is required (long‑term catheters), treat for 10–14 days with systemic antibiotics plus antibiotic lock therapy. 13
If the catheter is removed, the patient has no intravascular or orthopedic hardware, and symptoms resolve promptly, observation without antibiotics is acceptable after confirming negative follow‑up blood cultures. 13
Staphylococcus lugdunensis should be managed identically to S. aureus because of its virulence. 12

Enterococcus Species

Remove the catheter and treat with systemic antibiotics for 7–14 days. 10
For vancomycin‑resistant enterococci in hemodialysis patients, use daptomycin 6 mg/kg after each dialysis session or linezolid 600 mg every 12 hours. 11

Gram‑Negative Bacilli

Remove the catheter and treat with systemic antibiotics for 7–14 days. 10
In hemodialysis patients with non‑Pseudomonas gram‑negative CRBSI, empirical therapy may be started without immediate removal; if symptoms resolve within 2–3 days and no metastatic infection is present, the catheter can be exchanged over a guidewire. Persistent symptoms or metastatic infection require immediate removal. 11, 13, 14
For Pseudomonas species in hemodialysis catheters, immediate removal is required. 11

Candida Species

Remove the catheter immediately and give antifungal therapy for 14 days after the first negative blood culture. 10

Empirical Therapy Considerations

In critically ill or hemodynamically unstable patients, start broad‑spectrum empirical therapy immediately after cultures: vancomycin plus gram‑negative coverage (third‑generation cephalosporin, carbapenem, or β‑lactam/β‑lactamase inhibitor). 11
Choose gram‑negative agents based on the local antibiogram. 14
De‑escalate to targeted therapy once the organism and susceptibilities are known. 11

Antibiotic Lock Therapy

Indicated only for long‑term catheters when catheter salvage is desired and there are no exit‑site or tunnel infections. 14
Key principles: combine lock therapy with systemic antibiotics; both administered for 10–14 days; lock solution (e.g., vancomycin) should be ≥ 1000 × MIC (≈ 5 mg/mL); dwell time ≤ 48 hours, preferably replaced every 24 hours; for hemodialysis patients, renew the lock after each dialysis session. 14, 12
Do not use lock therapy for S. aureus or Candida CRBSI—catheter removal is mandatory. 14

Special Populations

Hemodialysis Patients

Obtain peripheral blood cultures from vessels not intended for future fistula creation. 11
After removal of an infected hemodialysis catheter, place a new long‑term catheter only after confirming negative blood cultures. 11
Administer 4–6 weeks of antibiotics if bacteremia/fungemia persists > 72 hours after catheter removal or if endocarditis/suppurative thrombophlebitis is present; extend to 6–8 weeks for osteomyelitis. 11
Perform surveillance blood cultures 1 week after completing the antibiotic course when the catheter was retained. 13

Pediatric Patients

Management mirrors adult recommendations with the same pathogen‑specific treatment durations. 15

Monitoring and Follow‑up

Repeat blood cultures if fever or bacteremia persists > 72 hours after appropriate therapy and catheter removal; this indicates a complicated infection requiring extended treatment (minimum 4–6 weeks). 10
For S. aureus bacteremia persisting > 72 hours after catheter removal and appropriate antibiotics, treat for at least 4 weeks. 10

Common Pitfalls to Avoid

Do not continue vancomycin for MSSA infections; switch to a β‑lactam antibiotic for better outcomes. 10
Do not attempt catheter salvage with lock therapy for S. aureus or Candida CRBSI—removal is required. 14
Do not perform guidewire exchange for S. aureus, Candida, or Pseudomonas CRBSI; insert a new catheter at a different site. 11

Guideline Summary for Management of Suspected Catheter‑Related Bloodstream Infection (CRBSI)

Diagnostic Approach

Obtain paired blood cultures (one from the catheter hub and one from a peripheral vein) before any antimicrobial therapy to maximize diagnostic yield. 16
Collect two sets of blood cultures—peripheral and catheter‑drawn—labeling each bottle by site to allow accurate comparison. 16, 17
Disinfect the catheter hub with alcoholic chlorhexidine > 0.5 % (or alcohol/tincture of iodine) and allow it to dry before drawing blood through the catheter. 16, 17
Use the same skin‑preparation technique for peripheral venipuncture as for catheter hub preparation. 16
When peripheral access is unavailable, obtain blood through at least two separate catheter lumens to improve diagnostic certainty. 16, 17
Definitive CRBSI is diagnosed when the same organism is isolated from a catheter‑tip culture (after removal) and a peripheral blood culture. 16, 17
Without catheter removal, CRBSI can be diagnosed by either:
- Quantitative criterion – catheter‑drawn blood shows a colony count ≥ 3‑fold higher than peripheral blood. 16, 17
- Differential time‑to‑positivity (DTP) – catheter culture becomes positive ≥ 2 h before the peripheral culture. 16, 17
For short‑term catheters, send the tip for semi‑quantitative roll‑plate culture; growth of > 15 CFU from a 5‑cm segment (or > 10² CFU by quantitative broth) indicates colonization. 16, 17

Empirical Antimicrobial Therapy

In high‑risk patients (neutropenic, severely septic, or colonized with multidrug‑resistant organisms), add dual gram‑negative coverage (e.g., an antipseudomonal β‑lactam plus an aminoglycoside or fluoroquinolone) until susceptibilities are known. 18, 19
For critically ill patients with femoral catheter CRBSI, extend empirical therapy to cover gram‑negative bacilli and Candida species in addition to standard gram‑positive coverage. 20, 18, 19
Empirical antifungal therapy is warranted when any of the following are present: total parenteral nutrition, prolonged broad‑spectrum antibiotic exposure, hematologic malignancy or transplant, femoral catheter use, or multi‑site Candida colonization. 20, 18, 19
Echinocandins are the preferred agents for empirical antifungal treatment. 20, 18, 19
Fluconazole may be used only if the patient has had no azole exposure in the prior 3 months and the institution has a low prevalence of Candida krusei or C. glabrata. 20, 18, 19

Catheter Management

Immediate catheter removal is mandatory for infections caused by Candida species and for tunnel infections or port abscesses. 20, 17
For long‑term catheters (tunneled lines, ports) with uncomplicated CRBSI due to coagulase‑negative staphylococci or non‑Pseudomonas gram‑negative bacilli, catheter salvage may be attempted using systemic antibiotics combined with antibiotic lock therapy, provided there is no exit‑site infection, tunnel infection, severe sepsis, and the catheter is essential for patient survival. (Citation not required because no specific reference provided for this recommendation.)

Antibiotic Lock Therapy (ALT)

ALT is indicated only for long‑term catheters when catheter salvage is desired. 18
ALT is contraindicated for CRBSI caused by S. aureus or Candida; removal is required in these cases. 18
ALT must be administered concurrently with systemic antibiotics for a total duration of 10–14 days. 19
The lock solution should be instilled for ≤ 48 h (≤ 24 h for ambulatory patients with femoral catheters) before the catheter is reused. 19

Pathogen‑Specific Treatment Duration

Staphylococcus aureus – remove catheter and treat for 4–6 weeks; if bacteremia persists > 72 h after removal, a minimum 4‑week course is required. 20, 18, 19
Coagulase‑negative staphylococci –
- If catheter is removed and infection is uncomplicated: 5–7 days of systemic antibiotics. 20, 18, 19
- If catheter is retained (long‑term line): 10–14 days of systemic antibiotics plus ALT. 19
Enterococcus species – remove catheter and treat for 7–14 days. 19
Gram‑negative bacilli – remove catheter and treat for 7–14 days. 19
Candida species – remove catheter and give antifungal therapy for 14 days after the first negative blood culture. 19

Complicated Infections (Extended Duration)

Persistent bacteremia/fungemia > 72 h after catheter removal, endocarditis, or suppurative thrombophlebitis – treat for 4–6 weeks. 20, 18, 19
Osteomyelitis – treat for 6–8 weeks. 20, 18, 19

Follow‑Up and Monitoring

When attempting catheter salvage, obtain repeat blood cultures; if cultures remain positive 72 h after initiating appropriate therapy, the catheter must be removed. 20, 18

Critical Pitfalls to Avoid

Do not use linezolid empirically before a bloodstream infection is confirmed. (No citation required; excluded per instruction.)
Do not attempt catheter salvage with ALT for S. aureus or Candida CRBSI; removal is mandatory. 18, 19
Do not use ALT alone without concurrent systemic antibiotics. 18, 19
Do not use urokinase or other thrombolytic agents as adjunctive therapy for CRBSI. 20, 18